Six-month operational test campaign involved regulators, airports, operators, and other key stakeholders.

DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast Track Designation ...

Munich, GermanyFollowing exceptional user retention rates in Europe’s most rigorous financial market, Gainorex ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...

A new study finds THC, when combined with an anti-inflammatory drug, improved memory and reduced Alzheimer’s-related brain ...

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

Iridium Communications Inc. (Nasdaq: IRDM), a leading provider of global voice, data, and PNT satellite services, today announced successful on-air testing of Iridium NTN Direct℠, including two-way ...

Researchers identify beta catenin protein degradation as a therapeutic vulnerability in B cell acute lymphoblastic leukaemia, supporting the repurposing of glycogen synthase kinase 3 beta inhibitors.

The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the ...

The FIM X-Trial Championship resumed in England, where Toni Bou scored another win to bolster his points lead.

The first mobile-originated message sent over the Iridium NTN Direct service read: "To Iridium and Beyond." Iridium NTN Direct is being developed as the world's first truly global, standards-based ...